Trials / Completed
CompletedNCT05723770
Effects of NOV03 on the Tear Film
Effects of NOV03 on the Tear Film in Subjects With Dry Eye Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Determine the effect of a single instillation of NOV03 on the thickness and evaporation rate of the mucus-aqueous layer of the tear film
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | instillation of NOV03 | This trial consists of 2 office visits over a period of approximately 2 weeks. At Visit 2, a designated clinical staff member or the investigator will instill 1 drop of NOV03 into each eye. |
Timeline
- Start date
- 2023-08-14
- Primary completion
- 2023-12-23
- Completion
- 2023-12-23
- First posted
- 2023-02-13
- Last updated
- 2025-07-04
- Results posted
- 2025-07-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05723770. Inclusion in this directory is not an endorsement.